All Regulation articles – Page 10
-
Business
Vaccine approvals offer hope as global Covid cases surge
A handful of vaccines are now approved and the first doses are being given to patients, with trials for many more candidates nearing completion
-
Business
Industry expects problems ahead after initial relief over Brexit deal
Uncertainty still looms over regulation and logistics
-
Business
Chemicals industry roundup 2020
Pandemic provides impetus to re-tune supply chains for resilience and sustainability
-
Business
Pharmaceuticals roundup 2020
Alongside the race for Covid-19 treatments and vaccines, the industry has maintained momentum
-
Research
Explainer: How would UK science be affected by a no-deal Brexit?
Access to EU science schemes, freedom of movement and student places are all expected to be disrupted
-
Business
Pfizer–BioNTech vaccine gains emergency approvals in US, Canada and beyond
UK begins vaccinating vulnerable populations after early authorisation
-
Business
UK grants Pfizer–BioNTech Covid-19 vaccine emergency approval
Regulators around the world working towards accelerated decisions on vaccine data
-
Business
Brexit may put some chemicals out of GB’s Reach
Industry fears divergence of UK and EU regulations could spell disaster for trade
-
News
Europeans want nanomaterial products to be labelled, survey shows
While awareness of nanomaterials in everyday products remains low, 87% of people want them noted, surveys in five European countries shows
-
Business
Regulatory panel unconvinced by Alzheimer’s antibody evidence
US FDA advisors vote against approving Biogen’s aducanumab on the basis of incomplete data analysis
-
News
Fresh calls for EU to review gene-edited crops regulations
Outdated legislation is hampering innovation and sustainability efforts, argue crop scientists
-
Opinion
A promising peep at Covid-19 vaccine efficacy
Pfizer–BioNTech’s will need to be one of many if we are to overcome the pandemic
-
Business
Early indications suggest Pfizer–BioNTech’s Covid-19 vaccine is effective
Company claims 90% efficacy at preventing disease, but experts call for data rather than press releases
-
Business
EU commits to overhaul of chemicals legislation
The Chemicals Strategy for Sustainability promises the biggest reform since Reach
-
Business
Covid-19 highlights need to update pharma supply chains
Resilience and redundancy are key amid protectionist calls for domestic manufacturing
-
News
Chemistry at work in e-liquids is still poorly understood, worrying researchers
New compounds with potentially harmful effects on the lungs can form from the mixture of flavours and solvents – even at room temperature
-
Webinar
The circular economy data challenge
Join us to gain a deeper understanding of the chemistry-focused data challenges in commercial circular economies
-
Opinion
Jumping the vaccine queue
Deals between companies and rich governments offset manufacturing risks, but must not compromise supplies to those in need
-
Business
Covid-19 vaccine deals risk skewing supply
International accords including Covax aiming to ensure equitable distribution to poorer countries